The role of thrombopoietin in chronic hepatitis B patients with thrombocytopenia
XU An-gao
Abstract
XU An-gao
Abstract
Objective:To explore the role of thrombopoietin in chronic hepatitis B patients with thrombocytopenia.Methods:The serum thrombopoietin levels,prothrombin activity,bone marrow megakaryocyte count were measured in 76 chronic hepatitis B patients with thrombocytopenia.Results:The serum thrombopoietin levels were correlated with parameters including coagulation activation,bone marrow megakaryocyte count,the platelet count(r was 0.423,0.396,0.297 respectively,P0.05).The bone marrow megakaryocyte count was below(7/4.5cm2) in 22 out of 76 patients.Megakaryocyte was dysmaturity in 29 out of 76 patients.Conclusion:The results suggest that decline of thrombopoietin may contribute to thrombocytopenia in chronic hepatitis B patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the role of thrombopoietin in chronic hepatitis B patients with thrombocytopenia.Methods:The serum thrombopoietin levels,prothrombin activity,bone marrow megakaryocyte count were measured in 76 chronic hepatitis B patients with thrombocytopenia.Results:The serum thrombopoietin levels were correlated with parameters including coagulation activation,bone marrow megakaryocyte count,the platelet count(r was 0.423,0.396,0.297 respectively,P0.05).The bone marrow megakaryocyte count was below(7/4.5cm2) in 22 out of 76 patients.Megakaryocyte was dysmaturity in 29 out of 76 patients.Conclusion:The results suggest that decline of thrombopoietin may contribute to thrombocytopenia in chronic hepatitis B patients.
Key concepts: Thrombopoietin, Megakaryocyte, Medicine, Platelet, Bone marrow, Prothrombin time, Chronic hepatitis, Internal medicine